Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
LRRN2 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Supplier: Thermo Scientific PA527923
Description
Recommended positive controls: U87-MG. Predicted reactivity: Mouse (93%), Rat (94%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The protein encoded by this gene belongs to the leucine-rich repeat superfamily. This gene was found to be amplified and overexpressed in malignant gliomas. The encoded protein has homology with other proteins that function as cell-adhesion molecules or as signal transduction receptors and is a candidate for the target gene in the 1q32.1 amplicon in malignant gliomas. Two alternatively spliced transcript variants encoding the same protein have been described for this gene.
Specifications
LRRN2 | |
Polyclonal | |
Unconjugated | |
LRRN2 | |
5730406J09Rik; fibronectin type III, immunoglobulin and leucine rich repeat domain 7; FIGLER7; GAC1; Glioma amplified on chromosome 1 protein; leucine rich and ankyrin repeats 1; leucine rich repeat neuronal 2; leucine rich repeat neuronal 5; leucine rich repeat protein 2, neuronal; leucine-rich repeat neuronal protein 2; Leucine-rich repeat neuronal protein 5; LRANK1; LRRN2; LRRN5; NLRR-2; UNQ256/PRO293 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
10446 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
O75325 | |
LRRN2 | |
Recombinant fragment corresponding to a region within amino acids 213 and 575 of Human LRRN2 | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction